← Back to all trials
Recruiting
NCT05602051
Mindfulness-based Virtual Reality Intervention
Conditions: Hematologic Neoplasms
Sex: All
Ages: 18 Years – 85 Years
Phase: NA
Enrollment: 110
Sponsor: Nanjing University of Traditional Chinese Medicine
Location: China
Summary
Through virtual reality technology and mindfulness therapy, we can intervene the patients with Hematologic Neoplasms during chemotherapy, hoping to improve their symptoms and self-efficacy.
Eligibility Criteria
Inclusion Criteria:Clinical diagnosis of Hematologic Neoplasms(leukemia, lymphoma or multiple myeloma) and receiving chemotherapyHospitalized for more than 4 weeksHave normal communication ability, clear consciousness, and willing to participate in this studyExclusion Criteria:People are cognitive dysfunction and audio-visual dysfunctionHave mental problems or have reported mental disorders
Source: ClinicalTrials.gov (NCT05602051). StuddyBuddy aggregates publicly available trial information.